Department of Neurology, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, Essen, Germany.
Department of Otolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
Clin Transl Sci. 2022 Nov;15(11):2709-2719. doi: 10.1111/cts.13397. Epub 2022 Sep 19.
Placebo effects substantially contribute to analgesic treatment outcomes and might be leveraged to enhance gold-standard treatments. The taste of oral medications has been proposed to boost placebo effects. Here, we aimed at estimating how far the taste of an oral medication enhances placebo analgesia. We conducted a randomized, double-blind, between-group, single-visit study, with pre-treatment baseline. Over the course of three substudies, 318 healthy volunteers (297 included) were tested in a clinical trial setting. Participants were subjected to experimental tonic cold water pain (cold pressor test) before and after receiving taste-neutral (water), or bitter (quinine), or sweet (saccharin), or no placebo drops. Pre- versus post-treatment changes in area under the pain rating curve, the main outcome, indicated that placebo treatment showed a small analgesic effect versus no treatment. Added taste induced placebo enhancement in the very small effect size range, but accounted for a substantial portion of the overall placebo effect. No noteworthy advantage of sweet over bitter placebo was observed. An exploration of heart rate (HR) recordings indicated that placebo treatments were associated with an increase in peak HR-response to cold water, but these were not associated with placebo analgesia at an individual level. Placebo treatments were associated with minimal side effects. These results indicate that added taste may be an easy-to-implement, cost-effective, and safe way to optimize treatment outcomes and that taste-neutral preparations may reduce placebo-related outcome variance in clinical trials. Further studies are needed to test if these findings can be translated into clinical scenarios.
安慰剂效应在很大程度上影响着镇痛治疗效果,可以被利用来增强金标准治疗。口服药物的味道被认为可以增强安慰剂效应。在这里,我们旨在估计口服药物的味道能在多大程度上增强安慰剂的镇痛作用。我们进行了一项随机、双盲、分组间、单次就诊的研究,有治疗前基线。在三个子研究中,318 名健康志愿者(297 名纳入)在临床试验环境中接受了测试。参与者在接受味觉中性(水)、苦味(奎宁)、甜味(糖精)或无安慰剂滴液之前和之后接受了实验性强直冷水疼痛(冷加压试验)。主要结果是疼痛评分曲线下面积的治疗前后变化,表明安慰剂治疗与无治疗相比具有较小的镇痛作用。额外的味道诱导了安慰剂在非常小的效应大小范围内增强,但占总体安慰剂效应的很大一部分。没有观察到甜味安慰剂优于苦味安慰剂的显著优势。对心率(HR)记录的探索表明,安慰剂治疗与冷水引起的峰值 HR 反应增加有关,但在个体水平上与安慰剂镇痛无关。安慰剂治疗与最小的副作用相关。这些结果表明,额外的味道可能是一种易于实施、具有成本效益和安全的方法,可以优化治疗效果,而且味觉中性制剂可能会减少临床试验中与安慰剂相关的结果变异性。需要进一步的研究来测试这些发现是否可以转化为临床情况。